Stem Cells and Cancer Stem Cells,Volume 3

PREFACE.-1. Introduction.-2. Diversity oriented fluorescence library approach for stem cell probe development.-3. Isolation of mesenchymal stem cells from umbilical cord (method).-4. Mesenchymal stem cell isolation and expansion methodology.-5.  Hair follicle stem cells.- 6. Rat embryonic cortical neural stem cells: role of hypoxia on cell proliferation and differentiation.-7. Human cord blood-derived hematopoietic stem and progenitor cells: from biology to medicine.-8. Proteomic characterization of mesenchymal stem cell-like populations derived from various tissue types.-9. The roles of nanog during early embryonic development and primordial germ cell migration.-10. Human embryonic stem cells in serum-free media: growth and metabolism. I. MOLECULAR GENETICS.-11. Evolutionary dynamics of mutations in hematopoietic stem cells and beyond.-12. Isolated corneal epithelial stem cells derived from limbal biopsies: use of lectin as a marker for identifying transient amplifying cells.-13. Stem cell distribution and mgmt expression in glioblastoma: role of intratumoral hypoxic gradient.- 14. Initiation of human tumourigenesis: upregulation of foxm1 transcription factor. II THERAPY.-15. Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy.-16.Ccell-based regenerative therapies: role of major histocompatibility complex-1 antigen.-17. Mesenchymal stem cells for cellular therapies.-18. Radiation burns and mesenchymal stem cell therapy.-19. Mesenchymal stem cells: role of mechanical strain in promoting apoptosis and differentiation.-20. Human mesenchymal stem cells: melatonin as a potential anti-osteoporosis drug.-21. Applications of human - induced pluripotent stem cell derived hepatocytes.-22. Stem cells and gastric carcinogenesis: from mouse to human.-23. Gain and loss of cancer stem cells: effect on metastatic efficiency and treatment response.-24. Treatment ofischemia/reperfusion injury of the kidney with mesenchymal stromal cells.-25. Mesenchymal stem cells: role for delivering nanoparticles to brain tumors.-26. Human induced pluripotent stem cells: role in patient specific drug discovery.-27. Biomedical applications of induced pluripotent stem cells.-28. Duchenne muscular dystrophy: isolation of cd133-expressing myogenic progenitors from blood and muscle of dmd patients. III TRANSPLANTATION.-29. Human fetal mesenchymal stem cells for prenatal and postnatal transplantation.-30. Protection of mice from stroke using hematopoietic stem cell transplantation.-31. Neonatel hypoxic-ischemic encephalopathy: neural stem/progenitor cell transplantation. IV TISSUE REGENERATION.-32. Mesenchymal stem cell-dependent formation and repair of tendon-done insertions.-33 . Cartilage injuries: role of implantation of human stem/progenitor cells.-34. Bone marrow-derived very small embryonic-like cells: β-cell regeneration in pancreatic tissue.- 35. Engineering stem cell niche: regulation of cellular morphology and function.- V APOPTOSIS.-36.  Embryonic stem cells: the role of nitric oxide in regulating cell differentiation, self-renewal, and apoptpsis.- 37. Induction of apoptosis in human keratinocyte stem cells: the role of hydrogen sulfide. Index